Similarly, insulin stimulates EPRS1 binding to SPEAR in differentiated adipocytes, possibly illuminating the clinical observation that insulin treatment, like obesity, is associated with increased mortality in COVID-19 patients [133]. This evidence concerns the gene EPRS1 and COVID-19.